Allspring Global Investments Holdings LLC Sells 59,201 Shares of Zoetis Inc. $ZTS

Allspring Global Investments Holdings LLC decreased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 61.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 37,241 shares of the company’s stock after selling 59,201 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Zoetis were worth $4,689,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. Mn Services Vermogensbeheer B.V. increased its holdings in shares of Zoetis by 2.9% during the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 173,669 shares of the company’s stock worth $21,851,000 after purchasing an additional 4,966 shares during the period. Vantage Wealth boosted its position in shares of Zoetis by 20.4% during the 4th quarter. Vantage Wealth now owns 130,555 shares of the company’s stock valued at $16,426,000 after acquiring an additional 22,085 shares in the last quarter. Spire Wealth Management grew its stake in shares of Zoetis by 5.9% in the 4th quarter. Spire Wealth Management now owns 5,317 shares of the company’s stock valued at $669,000 after purchasing an additional 294 shares during the period. Cascade Investment Advisors Inc. acquired a new position in Zoetis during the fourth quarter worth $1,499,000. Finally, Baron Wealth Management LLC boosted its position in Zoetis by 71.4% in the fourth quarter. Baron Wealth Management LLC now owns 2,965 shares of the company’s stock valued at $373,000 after buying an additional 1,235 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. The Goldman Sachs Group raised Zoetis to a “buy” rating in a report on Monday, December 15th. Bank of America boosted their target price on Zoetis from $135.00 to $140.00 and gave the stock a “neutral” rating in a report on Friday, February 13th. HSBC set a $140.00 target price on Zoetis in a report on Wednesday, December 10th. BTIG Research restated a “buy” rating and set a $160.00 target price on shares of Zoetis in a report on Thursday, February 26th. Finally, Wall Street Zen upgraded Zoetis from a “hold” rating to a “buy” rating in a report on Saturday, February 21st. Six equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $152.91.

Zoetis Stock Performance

ZTS stock opened at $116.87 on Wednesday. The company has a debt-to-equity ratio of 2.71, a current ratio of 3.03 and a quick ratio of 1.94. Zoetis Inc. has a fifty-two week low of $113.29 and a fifty-two week high of $172.23. The stock has a market capitalization of $49.34 billion, a PE ratio of 19.41, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a 50 day moving average price of $122.44 and a 200 day moving average price of $127.55.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The business had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.36 billion. During the same quarter in the prior year, the firm posted $1.40 earnings per share. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s dividend payout ratio (DPR) is 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.